IP Verse

Agents For Use In The Treatment Of Retinal Inflammation - EP3096781

PATENT ANALYSIS

Patent Details

Grant Date: Nov 2, 2022
Company: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.)
Oppositions

More patents of Centre National De La Recherche Scientifique (C.N.R.S.)

Want to monitor this patent?

Feel free to send us a message here and we will get back to you